- With the surge of cases during the third wave
of COVID-19, India faced a number of Mucormycosis
cases, a rare but potentially fatal fungal infection, caused
by the mucormycetes. The increased prevalence of
Mucormycosis among COVID-19 patients may be
associated with increased use of steroids, or the possible
immunocompromised state caused by SARS-CoV2 or coexisting conditions such as diabetes mellitus. Presenting
a case of Rhinomaxillary Mucormycosis where patient
presented with a complaint of ulcerative lesion on palate.
A diagnosis of Mucormycosis was established after
Contrast Enhanced Computed Tomography (CECT)
and cytology. Management was planned with antifungal
therapy and surgical intervention. Due to
immunocompromised state patient couldn’t survive
Keywords : COVID-19, Mucormycosis, Immunocomprised, Diabetes.